BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11263445)

  • 1. CD38 expression and Ig VH gene mutation in B-cell chronic lymphocytic leukemia.
    Matrai Z; Lin K; Dennis M; Sherrington P; Zuzel M; Pettitt AR; Cawley JC
    Blood; 2001 Mar; 97(6):1902-3. PubMed ID: 11263445
    [No Abstract]   [Full Text] [Related]  

  • 2. CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia.
    Thunberg U; Johnson A; Roos G; Thörn I; Tobin G; Sällström J; Sundström C; Rosenquist R
    Blood; 2001 Mar; 97(6):1892-4. PubMed ID: 11263438
    [No Abstract]   [Full Text] [Related]  

  • 3. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.
    Hamblin TJ; Orchard JA; Ibbotson RE; Davis Z; Thomas PW; Stevenson FK; Oscier DG
    Blood; 2002 Feb; 99(3):1023-9. PubMed ID: 11807008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia.
    Jelinek DF; Tschumper RC; Geyer SM; Bone ND; Dewald GW; Hanson CA; Stenson MJ; Witzig TE; Tefferi A; Kay NE
    Br J Haematol; 2001 Dec; 115(4):854-61. PubMed ID: 11843819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia.
    Ibrahim S; Keating M; Do KA; O'Brien S; Huh YO; Jilani I; Lerner S; Kantarjian HM; Albitar M
    Blood; 2001 Jul; 98(1):181-6. PubMed ID: 11418478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin V genes and CD38 expression in CLL.
    Hamblin TJ; Orchard JA; Gardiner A; Oscier DG; Davis Z; Stevenson FK
    Blood; 2000 Apr; 95(7):2455-7. PubMed ID: 10787241
    [No Abstract]   [Full Text] [Related]  

  • 7. CD38+CD8+ T cells as a marker of poor response to therapy in HIV-infected individuals.
    Vigano A; Saresella M; Villa ML; Ferrante P; Clerici M
    Chem Immunol; 2000; 75():207-17. PubMed ID: 10851786
    [No Abstract]   [Full Text] [Related]  

  • 8. CXCR4 expression is associated with survival in familial chronic lymphocytic leukemia, but CD38 expression is not.
    Ishibe N; Albitar M; Jilani IB; Goldin LR; Marti GE; Caporaso NE
    Blood; 2002 Aug; 100(3):1100-1. PubMed ID: 12150154
    [No Abstract]   [Full Text] [Related]  

  • 9. Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemia.
    Morabito F; Mangiola M; Oliva B; Stelitano C; Callea V; Deaglio S; Iacopino P; Brugiatelli M; Malavasi F
    Leuk Res; 2001 Nov; 25(11):927-32. PubMed ID: 11597727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD.
    Zupo S; Massara R; Dono M; Rossi E; Malavasi F; Cosulich ME; Ferrarini M
    Blood; 2000 Feb; 95(4):1199-206. PubMed ID: 10666191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia.
    Kröber A; Seiler T; Benner A; Bullinger L; Brückle E; Lichter P; Döhner H; Stilgenbauer S
    Blood; 2002 Aug; 100(4):1410-6. PubMed ID: 12149225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemia.
    Lin K; Sherrington PD; Dennis M; Matrai Z; Cawley JC; Pettitt AR
    Blood; 2002 Aug; 100(4):1404-9. PubMed ID: 12149224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia.
    D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Perla G; Savino L; Carotenuto M
    Leuk Lymphoma; 2001 Jun; 42(1-2):109-14. PubMed ID: 11699197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of CD38 expression in chronic lymphocytic leukemia.
    Del Poeta G; Maurillo L; Venditti A; Buccisano F; Epiceno AM; Capelli G; Tamburini A; Suppo G; Battaglia A; Del Principe MI; Del Moro B; Masi M; Amadori S
    Blood; 2001 Nov; 98(9):2633-9. PubMed ID: 11675331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single protein immunologically identified as CD38 displays NAD+ glycohydrolase, ADP-ribosyl cyclase and cyclic ADP-ribose hydrolase activities at the outer surface of human erythrocytes.
    Zocchi E; Franco L; Guida L; Benatti U; Bargellesi A; Malavasi F; Lee HC; De Flora A
    Biochem Biophys Res Commun; 1993 Nov; 196(3):1459-65. PubMed ID: 8250903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is chronic lymphocytic leukemia one disease?
    Hamblin T
    Haematologica; 2002 Dec; 87(12):1235-8. PubMed ID: 12495893
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia.
    Heintel D; Schwarzinger I; Chizzali-Bonfadin C; Thalhammer R; Schwarzmeier J; Fritzer-Szekeres M; Weltermann A; Simonitsch I; Lechner K; Jaeger U
    Leuk Lymphoma; 2001; 42(6):1315-21. PubMed ID: 11911414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia.
    Chevallier P; Penther D; Avet-Loiseau H; Robillard N; Ifrah N; Mahé B; Hamidou M; Maisonneuve H; Moreau P; Jardel H; Harousseau JL; Bataille R; Garand R
    Br J Haematol; 2002 Jan; 116(1):142-50. PubMed ID: 11841407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic lymphocytic leukemia: a proliferation of B cells at two distinct stages of differentiation.
    Damle RN; Fais F; Ghiotto F; Valetto A; Albesiano E; Wasil T; Batliwalla FM; Allen SL; Schulman P; Vinciguerra VP; Rai KR; Gregersen PK; Ferrarini M; Chiorazzi N
    Curr Top Microbiol Immunol; 2000; 252():285-92. PubMed ID: 11125486
    [No Abstract]   [Full Text] [Related]  

  • 20. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors.
    Oscier DG; Gardiner AC; Mould SJ; Glide S; Davis ZA; Ibbotson RE; Corcoran MM; Chapman RM; Thomas PW; Copplestone JA; Orchard JA; Hamblin TJ
    Blood; 2002 Aug; 100(4):1177-84. PubMed ID: 12149195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.